Skip to main content

Vericel Corp

VCEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000887359

In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 3 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Vericel Corp changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of VCEL: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders185197+12
Shares52.0M52.6M+637.3K (+1.2%)
Value$2.04B$2.01B−$29.0M (−1.4%)

New holders (33)

Institutions that held Vericel Corp at the end of Q1 2022 but not at the end of Q4 2021.

Sold out (21)

Institutions that held Vericel Corp at the end of Q4 2021 and filed for Q1 2022 without it.